Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2024-09-12 Sale |
2024-09-13 5:08 pm |
GILEAD SCIENCES INC. | GILD | Mercier Johanna Chief Commercial Officer |
29,357 | $83.78 | $2,459,577 | 78,127 (Direct) |
View |
2024-08-28 Sale |
2024-08-29 3:23 pm |
GILEAD SCIENCES INC. | GILD | Mercier Johanna Chief Commercial Officer |
9,513 | $78.03 | $742,299 | 105,466 (Direct) |
View |
2024-08-13 Sale |
2024-08-14 2:23 pm |
GILEAD SCIENCES INC. | GILD | Mercier Johanna Chief Commercial Officer |
5,490 | $73.98 | $406,150 | 114,979 (Direct) |
View |
2024-07-01 Sale |
2024-07-01 8:06 pm |
GILEAD SCIENCES INC. | GILD | Parsey Merdad Chief Medical Officer |
2,000 | $68.63 | $137,260 | 96,380 (Direct) |
View |
2024-06-17 Purchase |
2024-06-20 8:31 pm |
ASSEMBLY BIOSCIENCES INC. | ASMB | GILEAD SCIENCES INC. 10% Owner |
179,500 | $0 | $0 | 1,448,472 (Direct) |
View |
2024-04-02 Purchase |
2024-04-03 6:50 pm |
Xilio Therapeutics Inc. | XLO | GILEAD SCIENCES INC. 10% Owner |
485,250 | $0.76 | $368,790 | 11,227,923 (Direct) |
View |
2024-04-01 Sale |
2024-04-02 6:38 pm |
GILEAD SCIENCES INC. | GILD | Parsey Merdad Chief Medical Officer |
2,000 | $72.96 | $145,920 | 96,304 (Direct) |
View |
2024-02-28 Sale |
2024-02-29 6:35 pm |
GILEAD SCIENCES INC. | GILD | Parsey Merdad Chief Medical Officer |
10,230 | $72.82 | $744,984 | 92,706 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2024-09-10 Tax Withholding |
2024-09-11 7:41 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Telman Deborah H EVP, Corporate Affairs & GC |
307 | $81.44 | 50,254 (Direct) |
View |
2024-09-10 Exercise |
2024-09-11 7:41 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Telman Deborah H EVP, Corporate Affairs & GC |
639 | $0 | 50,254 (Direct) |
View |
2024-09-10 Tax Withholding |
2024-09-11 7:38 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Patterson Sandra SVP, Controllership |
292 | $81.44 | 49,768 (Direct) |
View |
2024-09-10 Exercise |
2024-09-11 7:38 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Patterson Sandra SVP, Controllership |
901 | $0 | 49,768 (Direct) |
View |
2024-09-10 Tax Withholding |
2024-09-11 7:33 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Parsey Merdad Chief Medical Officer |
1,766 | $81.44 | 139,008 (Direct) |
View |
2024-09-10 Exercise |
2024-09-11 7:33 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Parsey Merdad Chief Medical Officer |
3,821 | $0 | 139,008 (Direct) |
View |
2024-09-10 Tax Withholding |
2024-09-11 7:30 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | O'Day Daniel Patrick Chairman & CEO |
4,749 | $81.44 | 611,267 (Direct) |
View |
2024-09-10 Exercise |
2024-09-11 7:30 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | O'Day Daniel Patrick Chairman & CEO |
10,295 | $0 | 611,267 (Direct) |
View |
2024-09-10 Tax Withholding |
2024-09-11 7:23 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Mercier Johanna Chief Commercial Officer |
1,734 | $81.44 | 147,429 (Direct) |
View |
2024-09-10 Exercise |
2024-09-11 7:23 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Mercier Johanna Chief Commercial Officer |
3,752 | $0 | 147,429 (Direct) |
View |
2024-09-10 Tax Withholding |
2024-09-11 7:20 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer |
1,682 | $81.44 | 178,046 (Direct) |
View |
2024-09-10 Exercise |
2024-09-11 7:20 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer |
3,641 | $0 | 178,046 (Direct) |
View |
2024-08-10 Tax Withholding |
2024-08-12 4:22 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Patterson Sandra SVP, Controllership |
980 | $73.66 | 50,060 (Direct) |
View |
2024-08-10 Exercise |
2024-08-12 4:22 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Patterson Sandra SVP, Controllership |
3,678 | $0 | 50,060 (Direct) |
View |
2024-07-25 Tax Withholding |
2024-07-26 5:28 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Telman Deborah H EVP, Corporate Affairs & GC |
2,917 | $76.51 | 88,977 (Direct) |
View |
2024-07-25 Exercise |
2024-07-26 5:28 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Telman Deborah H EVP, Corporate Affairs & GC |
8,744 | $0 | 88,977 (Direct) |
View |
2024-06-10 Exercise |
2024-06-11 7:25 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer |
3,639 | $0 | 179,728 (Direct) |
View |
2024-06-10 Tax Withholding |
2024-06-11 7:25 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer |
1,662 | $65.25 | 179,728 (Direct) |
View |
2024-06-10 Exercise |
2024-06-11 7:23 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Patterson Sandra SVP, Controllership |
901 | $0 | 51,040 (Direct) |
View |
2024-06-10 Tax Withholding |
2024-06-11 7:23 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Patterson Sandra SVP, Controllership |
255 | $65.25 | 51,040 (Direct) |
View |
2024-06-10 Exercise |
2024-06-11 7:20 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | O'Day Daniel Patrick Chairman & CEO |
10,295 | $0 | 616,016 (Direct) |
View |
2024-06-10 Tax Withholding |
2024-06-11 7:20 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | O'Day Daniel Patrick Chairman & CEO |
4,693 | $65.25 | 616,016 (Direct) |
View |
2024-06-10 Exercise |
2024-06-11 7:18 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Mercier Johanna Chief Commercial Officer |
3,751 | $0 | 164,166 (Direct) |
View |
2024-06-10 Tax Withholding |
2024-06-11 7:18 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Mercier Johanna Chief Commercial Officer |
1,714 | $65.25 | 164,166 (Direct) |
View |
2024-06-10 Exercise |
2024-06-11 7:15 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Parsey Merdad Chief Medical Officer |
3,820 | $0 | 142,774 (Direct) |
View |
2024-06-10 Tax Withholding |
2024-06-11 7:15 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Parsey Merdad Chief Medical Officer |
1,744 | $65.25 | 142,774 (Direct) |
View |
2024-06-10 Exercise |
2024-06-11 7:12 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Telman Deborah H EVP, Corporate Affairs & GC |
638 | $0 | 53,478 (Direct) |
View |
2024-06-10 Tax Withholding |
2024-06-11 7:12 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Telman Deborah H EVP, Corporate Affairs & GC |
204 | $65.25 | 53,478 (Direct) |
View |
2024-05-08 Option Award |
2024-05-09 5:57 pm |
N/A 2034-05-08 |
GILEAD SCIENCES INC. | GILD | BARTON JACQUELINE K Director |
14,958 | $0 | 37,188 (Direct) |
View |
2024-05-08 Option Award |
2024-05-09 5:30 pm |
N/A 2034-05-08 |
GILEAD SCIENCES INC. | GILD | LOVE TED W Director |
14,958 | $0 | 15,470 (Direct) |
View |
2024-05-08 Option Award |
2024-05-09 5:26 pm |
N/A 2034-05-08 |
GILEAD SCIENCES INC. | GILD | Rodriguez Javier Director |
14,958 | $0 | 23,350 (Direct) |
View |
2024-05-08 Option Award |
2024-05-09 5:23 pm |
N/A 2034-05-08 |
GILEAD SCIENCES INC. | GILD | WELTERS ANTHONY Director |
14,958 | $0 | 22,880 (Direct) |
View |
2024-05-08 Option Award |
2024-05-09 5:16 pm |
N/A 2034-05-08 |
GILEAD SCIENCES INC. | GILD | MANWANI HARISH Director |
14,958 | $0 | 25,521 (Direct) |
View |
2024-05-08 Tax Withholding |
2024-05-09 5:16 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | MANWANI HARISH Director |
451 | $64.92 | 25,521 (Direct) |
View |
2024-05-08 Option Award |
2024-05-09 5:08 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Bluestone Jeffrey Director |
14,958 | $0 | 16,845 (Direct) |
View |
2024-05-08 Option Award |
2024-05-09 3:46 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Horning Sandra Director |
14,958 | $0 | 20,449 (Direct) |
View |
2024-05-08 Option Award |
2024-05-09 3:38 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Kramer Kelly A. Director |
14,958 | $0 | 30,242 (Direct) |
View |
2024-04-25 Tax Withholding |
2024-04-26 4:30 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Telman Deborah H EVP, Corporate Affairs & GC |
158 | $65.27 | 53,682 (Direct) |
View |
2024-04-25 Exercise |
2024-04-26 4:30 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Telman Deborah H EVP, Corporate Affairs & GC |
515 | $0 | 53,682 (Direct) |
View |
Ownership |
2024-04-19 4:31 pm |
N/A N/A |
LEAP THERAPEUTICS INC. | LPTX | GILEAD SCIENCES INC. 10% Owner |
0 | $0 | 5,319,148 (Direct) |
View |
Ownership |
2024-04-03 6:48 pm |
N/A N/A |
Xilio Therapeutics Inc. | XLO | GILEAD SCIENCES INC. 10% Owner |
0 | $0 | 6,860,223 (Direct) |
View |
2024-03-28 Option Award |
2024-03-29 5:19 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Lofton Kevin E Director |
34 | $0 | 3,258 (Direct) |
View |
2024-03-10 Option Award |
2024-03-12 4:19 pm |
N/A 2034-03-10 |
GILEAD SCIENCES INC. | GILD | Telman Deborah H EVP, Corporate Affairs & GC |
65,795 | $0 | 138,088 (Direct) |
View |
2024-03-10 Tax Withholding |
2024-03-12 4:19 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Telman Deborah H EVP, Corporate Affairs & GC |
846 | $75.12 | 138,088 (Direct) |
View |
2024-03-10 Exercise |
2024-03-12 4:19 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Telman Deborah H EVP, Corporate Affairs & GC |
2,555 | $0 | 138,088 (Direct) |
View |
2024-03-10 Option Award |
2024-03-12 3:57 pm |
N/A 2034-03-10 |
GILEAD SCIENCES INC. | GILD | Patterson Sandra SVP, Controllership |
18,485 | $0 | 94,565 (Direct) |
View |
2024-03-10 Tax Withholding |
2024-03-12 3:57 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Patterson Sandra SVP, Controllership |
790 | $75.12 | 94,565 (Direct) |
View |
2024-03-10 Exercise |
2024-03-12 3:57 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Patterson Sandra SVP, Controllership |
2,682 | $0 | 94,565 (Direct) |
View |
2024-03-10 Option Award |
2024-03-11 9:14 pm |
N/A 2034-03-10 |
GILEAD SCIENCES INC. | GILD | Parsey Merdad Chief Medical Officer |
107,300 | $0 | 304,272 (Direct) |
View |
2024-03-10 Tax Withholding |
2024-03-11 9:14 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Parsey Merdad Chief Medical Officer |
4,803 | $75.12 | 304,272 (Direct) |
View |
2024-03-10 Exercise |
2024-03-11 9:14 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Parsey Merdad Chief Medical Officer |
10,401 | $0 | 304,272 (Direct) |
View |
2024-03-10 Option Award |
2024-03-11 9:11 pm |
N/A 2034-03-10 |
GILEAD SCIENCES INC. | GILD | O'Day Daniel Patrick Chairman & CEO |
334,040 | $0 | 1,080,883 (Direct) |
View |
2024-03-10 Tax Withholding |
2024-03-11 9:11 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | O'Day Daniel Patrick Chairman & CEO |
13,782 | $75.12 | 1,080,883 (Direct) |
View |
2024-03-10 Exercise |
2024-03-11 9:11 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | O'Day Daniel Patrick Chairman & CEO |
29,940 | $0 | 1,080,883 (Direct) |
View |
2024-03-10 Option Award |
2024-03-11 9:03 pm |
N/A 2034-03-10 |
GILEAD SCIENCES INC. | GILD | Mercier Johanna Chief Commercial Officer |
105,275 | $0 | 320,955 (Direct) |
View |
2024-03-10 Tax Withholding |
2024-03-11 9:03 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Mercier Johanna Chief Commercial Officer |
4,559 | $75.12 | 320,955 (Direct) |
View |
2024-03-10 Exercise |
2024-03-11 9:03 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Mercier Johanna Chief Commercial Officer |
9,844 | $0 | 320,955 (Direct) |
View |
2024-03-10 Option Award |
2024-03-11 8:59 pm |
N/A 2034-03-10 |
GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer |
105,275 | $0 | 332,733 (Direct) |
View |
2024-03-10 Tax Withholding |
2024-03-11 8:59 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer |
4,505 | $75.12 | 332,733 (Direct) |
View |
2024-03-10 Exercise |
2024-03-11 8:59 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer |
9,732 | $0 | 332,733 (Direct) |
View |